These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Current problem in integration of the antituberculosis campaign in the overall medical and health networks]. Mihailescu P Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1979; 28(1):1-5. PubMed ID: 223219 [No Abstract] [Full Text] [Related]
26. Tuberculosis II: the failure of the BCG vaccine. Maes RF Med Hypotheses; 1999 Jul; 53(1):32-9. PubMed ID: 10499822 [TBL] [Abstract][Full Text] [Related]
27. [From the experience of an antituberculosis department of a rural district hospital]. Mansurov AP Probl Tuberk; 1966; 44(11):8-10. PubMed ID: 4236879 [No Abstract] [Full Text] [Related]
28. The geographic location (latitude) of studies evaluating protective effect of BCG vaccine and it's efficacy/effectiveness against tuberculosis. Zodpey SP; Shrikhande SN Indian J Public Health; 2007; 51(4):205-10. PubMed ID: 18232158 [TBL] [Abstract][Full Text] [Related]
29. BCG vaccination and WHO's global strategy for tuberculosis control 1948-1983. Brimnes N Soc Sci Med; 2008 Sep; 67(5):863-73. PubMed ID: 18573583 [TBL] [Abstract][Full Text] [Related]
30. [Antituberculosis vaccination with B.C.G. II. Practical application at the C.P.A. of Turin]. Concina E; Gaglio L; Morbidelli L; Orlandi A G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1969; 62(5):345-66. PubMed ID: 5376909 [No Abstract] [Full Text] [Related]
31. [Nontuberculous pneumonia in the practice of an antituberculosis dispensary (clinical aspects)]. Sorkin IE Klin Med (Mosk); 1967 Dec; 45(12):82-6. PubMed ID: 5606976 [No Abstract] [Full Text] [Related]
32. Preventing tuberculosis with bacillus Calmette-Guérin vaccine: a meta-analysis of the literature. Brewer TF Clin Infect Dis; 2000 Sep; 31 Suppl 3():S64-7. PubMed ID: 11010824 [TBL] [Abstract][Full Text] [Related]
33. The success and failure of BCG - implications for a novel tuberculosis vaccine. Andersen P; Doherty TM Nat Rev Microbiol; 2005 Aug; 3(8):656-62. PubMed ID: 16012514 [TBL] [Abstract][Full Text] [Related]
34. The BCG controversy: a reappraisal of the protective effect against tuberculosis and leprosy. Zodpey SP Indian J Public Health; 2004; 48(2):70-7. PubMed ID: 15709589 [TBL] [Abstract][Full Text] [Related]
35. Anti-tuberculosis drug susceptibility testing of Mycobacterium bovis BCG Tokyo strain. Shishido Y; Mitarai S; Otomo K; Seki M; Sato A; Yano I; Koyama A; Hattori T Int J Tuberc Lung Dis; 2007 Dec; 11(12):1334-8. PubMed ID: 18034955 [TBL] [Abstract][Full Text] [Related]
36. [Experience from active immunization of newborn against tuberculosis with BCG and M vaccine in the years 1950-52]. SRAMKOVA J Pediatr Listy; 1954; 9(5):286-8. PubMed ID: 14356784 [No Abstract] [Full Text] [Related]
37. [BCG vaccination of medical students of the University of Naples: findings concerning the evolution of the vaccination site and the BCG allergy]. Galzerano G; Dericoloso A; Goatley ML; Mazzarella G Arch Monaldi; 1980; 35(3):143-7. PubMed ID: 7316664 [No Abstract] [Full Text] [Related]
38. [Tuberculosis prevention with BCG vaccine and methods for increasing its effectiveness]. Shvartser IS; Klepatskaia SB Probl Tuberk; 1983 Mar; (3):10-4. PubMed ID: 6222373 [No Abstract] [Full Text] [Related]
39. [History of anti-tuberculosis vaccination and the development of BCG vaccine]. Moskwa Z Wiad Lek; 1983 Jan; 36(1):81-5. PubMed ID: 6342271 [No Abstract] [Full Text] [Related]
40. [Development of protective antituberculosis immunity after BCG vaccination in mice with silicon deficiency in water and feed]. Akuginova ZD; Akuginova GE; Mezhlumova MB; Avdienko VG; Nikonenko BV Probl Tuberk; 1995; (2):23-4. PubMed ID: 7777456 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]